Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management -A Multi-center, Prospective, Interventional Study (PRECEDE)

NCT06909773 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06909773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06909773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management -A Multi-center, Prospective, Interventional Study (PRECEDE)
Lead sponsor
AstraZeneca
Phase
Not applicable
Overall status
Recruiting
Start date
November 28, 2025
Completion date
December 31, 2026
Enrollment
3,000 (estimated)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases